A prospective, randomized trial comparing the effect of intravenous omeprazole to that of intravenous ranitidine on the maintenance of hemostasis after successful endoscopic treatment of bleeding peptic ulcer

Status: Withdrawn prior to enrolment

Phase of Trial: Phase IV

Latest Information Update: 18 Sep 2021

Price : $35 ^*

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Omeprazole; Ranitidine
Indications Bleeding ulcer
Focus Therapeutic Use

Most Recent Events

03 Apr 2015 Biomarkers information updated
03 Jul 2007 Status changed from initiated to withdrawn prior to recruitment.
20 Nov 2005 New trial record.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com

Welcome to AdisInsight